Insomnia

Source: Wikipedia, the free encyclopedia.
This article is about the sleeping disorder. For other uses, see Insomnia (disambiguation).
"Trouble sleeping" redirects here. For other uses, see Trouble sleeping (disambiguation).
Insomnia
Other namesSleeplessness, trouble sleeping
sleeping pills[5][6][7]
Frequency~20%[8][9][10]

Insomnia, also known as sleeplessness, is a

sleeping.[1] They may have difficulty falling asleep, or staying asleep for as long as desired.[1][9][11] Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.[1] It may result in an increased risk of accidents of all kinds as well as problems focusing and learning.[9] Insomnia can be short term, lasting for days or weeks, or long term, lasting more than a month.[1] The concept of the word insomnia has two possibilities: insomnia disorder (ID) and insomnia symptoms, and many abstracts of randomized controlled trials and systematic reviews often underreport on which of these two possibilities the word insomnia refers to.[12]

Insomnia can occur independently or as a result of another problem.

night shifts and sleep apnea.[9] Diagnosis is based on sleep habits and an examination to look for underlying causes.[3] A sleep study may be done to look for underlying sleep disorders.[3] Screening may be done with two questions: "do you experience difficulty sleeping?" and "do you have difficulty falling or staying asleep?"[9]

Although their efficacy as first line treatments is not unequivocally established,

injuries, dementia, and addiction.[5][6] These medications are not recommended for more than four or five weeks.[6] The effectiveness and safety of alternative medicine is unclear.[5][6]

Between 10% and 30% of adults have insomnia at any given point in time and up to half of people have insomnia in a given year.[8][9][10] About 6% of people have insomnia that is not due to another problem and lasts for more than a month.[9] People over the age of 65 are affected more often than younger people.[7] Women are more often affected than men.[8] Descriptions of insomnia occur at least as far back as ancient Greece.[15]

Signs and symptoms

Potential complications of insomnia[16]

Symptoms of insomnia:[17]

  • Difficulty falling asleep, including difficulty finding a comfortable
    sleeping position
  • Waking during the night, being unable to return to sleep and waking up early
  • Not able to focus on daily tasks, difficulty in remembering
  • Daytime sleepiness, irritability, depression or anxiety
  • Feeling tired or having low energy during the day[18]
  • Trouble concentrating
  • Being irritable, acting aggressive or impulsive

Sleep onset insomnia is difficulty falling asleep at the beginning of the night, often a symptom of anxiety disorders. Delayed sleep phase disorder can be misdiagnosed as insomnia, as sleep onset is delayed to much later than normal while awakening spills over into daylight hours.[19]

It is common for patients who have difficulty falling asleep to also have nocturnal awakenings with difficulty returning to sleep. Two-thirds of these patients wake up in the middle of the night, with more than half having trouble falling back to sleep after a middle-of-the-night awakening.[20]

Early morning awakening is an awakening occurring earlier (more than 30 minutes) than desired with an inability to go back to sleep, and before total sleep time reaches 6.5 hours. Early morning awakening is often a characteristic of

tension, compulsive worrying about the future, feeling overstimulated, and overanalyzing past events.[22]

Poor sleep quality

Poor sleep quality can occur as a result of, for example,

major depression. Poor sleep quality is defined as the individual not reaching stage 3 or delta sleep which has restorative properties.[23]

Major depression leads to alterations in the function of the hypothalamic–pituitary–adrenal axis, causing excessive release of cortisol which can lead to poor sleep quality.

Nocturnal polyuria, excessive night-time urination, can also result in a poor quality of sleep.[24]

Subjectivity

Main article: Sleep state misperception

Some cases of insomnia are not really insomnia in the traditional sense, because people experiencing sleep state misperception often sleep for a normal amount of time.[25] The problem is that, despite sleeping for multiple hours each night and typically not experiencing significant daytime sleepiness or other symptoms of sleep loss, they do not feel like they have slept very much, if at all.[25] Because their perception of their sleep is incomplete, they incorrectly believe it takes them an abnormally long time to fall asleep, and they underestimate how long they stay asleep.[25]

Problematic digital media use

See also: Screen time, Binge-watching, Internet addiction disorder, Nomophobia, Problematic smartphone use, Problematic social media use, Television addiction, and Video game addiction
This section is an excerpt from Digital media use and mental health § Insomnia.[edit]

In August 2018, Sleep Science and Practice published a systematic review and meta-analysis of 19 studies comprising 253,904 adolescent subjects that found that excessive technology use had a strong and consistent association with reduced sleep duration and prolonged sleep onset latency for adolescents 14 years of age or older.[26] Also in August 2018, Sleep Science published a systematic review of 12 studies investigating associations between exposure to video games, sleep outcomes, and post-sleep cognitive abilities that found the data present in the studies indicated associations between a reduction in sleep duration, increased sleep onset latency, modifications to rapid eye movement sleep and slow-wave sleep, increased sleepiness and self-perceived fatigue, and impaired post-sleep attention span and verbal memory.[27] In October 2019, Sleep Medicine Reviews published a systematic review and meta-analysis of 23 studies comprising 35,684 subjects that found a statistically significant odds ratio for sleep problems and reduced sleep duration for subjects with internet addiction.[28] In February 2020, Psychiatry Research published a systematic review and meta-analysis of 14 studies that found positive associations between problematic smartphone use and poor sleep quality and between higher levels of problematic smartphone use and elevated risk of poor sleep quality.[29]

Also in February 2020, Sleep Medicine Reviews published a systematic review of 31 studies examining associations between screen time and sleep outcomes in children younger than 5 years and found that screen time is associated with poorer sleep outcomes for children under the age of 5, with meta-analysis only confirming poor sleep outcomes among children under 2 years.[30] In March 2020, Developmental Review published a systematic review of 9 studies that found a weak-to-moderate association between sleep quantity and quality and problematic smartphone use among adolescents.[31] In October 2020, the International Journal of Environmental Research and Public Health published a systematic review and meta-analysis of 80 studies that found that greater screen time was associated with shorter sleep duration among toddlers and preschoolers,[32] while the Journal of Behavioral Addictions published a systematic review and meta-analysis of 40 studies with 33,650 post-secondary student subjects that found a weak-to-moderate positive association between mobile phone addiction and poor sleep quality.[33] In April 2021, Sleep Medicine Reviews published a systematic review of 36 cross-sectional studies and 6 longitudinal studies that found that 24 of the cross-sectional studies and 5 of the longitudinal studies established significant associations between more frequent social media use and poor sleep outcomes.[34]

In June 2021, Frontiers in Psychiatry published a systematic review and meta-analysis of 34 studies comprising 51,901 subjects that established significant associations between problematic gaming and sleep duration, poor sleep quality, daytime sleepiness, and other sleep problems.[35] In September 2021, BMC Public Health published a systematic review of 49 studies investigating associations between electronic media use and various sleep outcomes among children and adolescents 15 years of age or younger that found a strong association with sleep duration and stronger evidence for an association with sleep duration between the ages of 6 and 15 years than for 5 years of age or younger, while evidence for associations between electronic media use with other sleep outcomes was more inconclusive.[36] In December 2021, Frontiers in Neuroscience published a systematic review of 12 studies published from January 2000 to April 2020 that found that adult subjects with higher gaming addiction scores were more likely to have shorter sleep quantity, poorer sleep quality, delayed sleep timing, and greater daytime sleepiness and insomnia scores than subjects with lower gaming addiction scores and non-gamer subjects.[37] In January 2022, Early Childhood Research Quarterly published a systematic review and meta-analysis of 26 studies that found a weak but statistically significant association with increased smartphone and tablet computer use and poorer sleep in early childhood.[38]

In May 2022, the Journal of Affective Disorders published a meta-analysis of 29 studies comprising 20,041 subjects that found a weak-to-moderate association between mobile phone addiction and sleep disorder and that adolescents with mobile phone addiction were at higher risk of developing sleep disorder.[39] In August 2022, the International Journal of Environmental Research and Public Health published a systematic review and meta-analysis of 16 studies comprising 8,077 subjects that established a significant association between binge-watching and sleep problems and a stronger association between binge-watching and sleep problems was found during the COVID-19 pandemic than pre-pandemic.[40] In October 2022, Reports in Public Health published a systematic review of 23 studies that found that excessive use of digital screens by adolescents was associated with poor sleep quality, nighttime awakenings, long sleep latency, and daytime sleepiness.[41] In December 2022, Sleep Epidemiology published a systematic review of 18 studies investigating associations between sleep problems and screen time during COVID-19 lockdowns that found that the increased screen time during the lockdowns negatively impacted sleep duration, sleep quality, sleep onset latency, and wake time.[42] In March 2023, the Journal of Clinical Sleep Medicine published a systematic review and meta-analysis of 17 studies comprising 36,485 subjects that found that smartphone overuse was closely associated with self-reported poor sleep quality, sleep deprivation, and prolonged sleep latency.[43]

In April 2023, Sleep Medicine Reviews published a systematic review of 42 studies that found digital media use to be associated with shorter sleep duration and poorer sleep quality and bedtime or nighttime use with poor sleep outcomes, but only found associations for general screen use, mobile phone use, computer and internet use, internet, and social media and not for television, game console, and tablet use.[44] In July 2023, Healthcare published a systematic review and meta-analysis of 16 studies that established a correlation coefficient of 0.56 between nomophobia and insomnia.[45] In September 2023, PLOS One published a systematic review and meta-analysis of 16 studies of smartphone addiction and sleep among medical students found that 57% of subjects had poor sleep and 39% of subjects had smartphone addiction with a correlation index of 0.3,[46] while Computers in Human Behavior published a meta-analysis of 23 longitudinal studies comprising 116,431 adolescent subjects that found that adolescent screen time with computers, smartphones, social media, and television are positively associated with negative impacts on sleep health later in life.[47]

Causes

While insomnia can be caused by a number of conditions, it can also occur without any identifiable cause. This is known as Primary Insomnia.[48] Primary Insomnia may also have an initial identifiable cause, but continues after the cause is no longer present. For example, a bout of insomnia may be triggered by a stressful work or life event. However the condition may continue after the stressful event has been resolved. In such cases, the insomnia is usually perpetuated by the anxiety or fear caused by the sleeplessness itself, rather than any external factors.[49]

Symptoms of insomnia can be caused by or be associated with:

Sleep studies using polysomnography have suggested that people who have sleep disruption have elevated night-time levels of circulating cortisol and adrenocorticotropic hormone.[66] They also have an elevated metabolic rate, which does not occur in people who do not have insomnia but whose sleep is intentionally disrupted during a sleep study. Studies of brain metabolism using positron emission tomography (PET) scans indicate that people with insomnia have higher metabolic rates by night and by day. The question remains whether these changes are the causes or consequences of long-term insomnia.[67]

Genetics

genes that influence the risk of insomnia, and showed that insomnia is highly polygenic.[69] In particular, a strong positive association was observed for the MEIS1
gene in both males and females. This study showed that the genetic architecture of insomnia strongly overlaps with psychiatric disorders and metabolic traits.

It has been hypothesized that epigenetics might also influence insomnia through a controlling process of both sleep regulation and brain-stress response having an impact as well on the brain plasticity.[70]

Substance-induced

Alcohol-induced

Main article: Alcohol use and sleep

Alcohol is often used as a form of self-treatment of insomnia to induce sleep. However, alcohol use to induce sleep can be a cause of insomnia.

excessive sweating. Glutamine
rebound also plays a role as when someone is drinking; alcohol inhibits glutamine, one of the body's natural stimulants. When the person stops drinking, the body tries to make up for lost time by producing more glutamine than it needs. The increase in glutamine levels stimulates the brain while the drinker is trying to sleep, keeping them from reaching the deepest levels of sleep.[71] Stopping chronic alcohol use can also lead to severe insomnia with vivid dreams. During withdrawal, REM sleep is typically exaggerated as part of a rebound effect.[72]

Benzodiazepine-induced

Like alcohol,

sleep architecture: decreasing sleep time, delaying time to REM sleep, and decreasing deep slow-wave sleep (the most restorative part of sleep for both energy and mood).[73][74][75]

Opioid-induced

analgesia and sedation, opioids may be appropriate in carefully selected patients with pain-associated insomnia.[55] However, dependence on opioids can lead to long-term sleep disturbances.[76]

Risk factors

Insomnia affects people of all age groups but people in the following groups have a higher chance of acquiring insomnia:[77]

  • Individuals older than 60
  • History of mental health disorder including depression, etc.
  • Emotional stress
  • Working late night shifts
  • Traveling through different time zones[11]
  • Having chronic diseases such as
    Alzheimer's, or heart disease[78]
  • Alcohol or drug use disorders
  • Gastrointestinal reflux disease
  • Heavy smoking
  • Work stress[79]
  • Individuals of low SES[80]
  • Urban Neighborhoods [80]
  • Household stress[80]

Mechanism

Two main models exists as to the mechanism of insomnia, cognitive and physiological. The cognitive model suggests rumination and hyperarousal contribute to preventing a person from falling asleep and might lead to an episode of insomnia.

The physiological model is based upon three major findings in people with insomnia; firstly, increased urinary

electroencephalograms; however, the implication of this is unknown.[83]

Around half of post-menopausal women experience sleep disturbances, and generally sleep disturbance is about twice as common in women as men; this appears to be due in part, but not completely, to changes in hormone levels, especially in and post-menopause.[56][84]

Changes in sex hormones in both men and women as they age may account in part for increased prevalence of sleep disorders in older people.[85]

Diagnosis

In medicine, insomnia is widely measured using the

Athens insomnia scale.[86]
It is measured using eight different parameters related to sleep, finally represented as an overall scale which assesses an individual's sleep pattern.

A qualified sleep specialist should be consulted for the diagnosis of any sleep disorder so the appropriate measures can be taken. Past medical history and a physical examination need to be done to eliminate other conditions that could be the cause of insomnia. After all other conditions are ruled out a comprehensive sleep history should be taken. The sleep history should include sleep habits, medications (prescription and non-prescription), alcohol consumption, nicotine and caffeine intake, co-morbid illnesses, and sleep environment.[87] A sleep diary can be used to keep track of the individual's sleep patterns. The diary should include time to bed, total sleep time, time to sleep onset, number of awakenings, use of medications, time of awakening, and subjective feelings in the morning.[87] The sleep diary can be replaced or validated by the use of out-patient actigraphy for a week or more, using a non-invasive device that measures movement.[88]

Workers who complain of insomnia should not routinely have

oropharynx.[89] Usually, the test is not needed to make a diagnosis, and insomnia especially for working people can often be treated by changing a job schedule to make time for sufficient sleep and by improving sleep hygiene.[89]

Some patients may need to do an overnight sleep study to determine if insomnia is present. Such a study will commonly involve assessment tools including a polysomnogram and the

multiple sleep latency test. Specialists in sleep medicine are qualified to diagnose disorders within the, according to the ICSD, 81 major sleep disorder diagnostic categories.[90] Patients with some disorders, including delayed sleep phase disorder
, are often mis-diagnosed with primary insomnia; when a person has trouble getting to sleep and awakening at desired times, but has a normal sleep pattern once asleep, a circadian rhythm disorder is a likely cause.

In many cases, insomnia is co-morbid with another disease, side-effects from medications, or a psychological problem. Approximately half of all diagnosed insomnia is related to psychiatric disorders.[91] For those who have depression, "insomnia should be regarded as a co-morbid condition, rather than as a secondary one;" insomnia typically predates psychiatric symptoms.[91] "In fact, it is possible that insomnia represents a significant risk for the development of a subsequent psychiatric disorder."[9] Insomnia occurs in between 60% and 80% of people with depression.[92] This may partly be due to treatment used for depression.[92]

Determination of causation is not necessary for a diagnosis.[91]

DSM-5 criteria

The DSM-5 criteria for insomnia include the following:[93]

Predominant complaint of dissatisfaction with sleep quantity or quality, associated with one (or more) of the following symptoms:

  • Difficulty initiating sleep. (In children, this may manifest as difficulty initiating sleep without caregiver intervention.)
  • Difficulty maintaining sleep, characterized by frequent awakenings or problems returning to sleep after awakenings. (In children, this may manifest as difficulty returning to sleep without caregiver intervention.)
  • Early-morning awakening with inability to return to sleep.

In addition:

  • The sleep disturbance causes clinically significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning.
  • The sleep difficulty occurs at least three nights per week.
  • The sleep difficulty is present for at least three months.
  • The sleep difficulty occurs despite adequate opportunity for sleep.
  • The insomnia is not better explained by and does not occur exclusively during the course of another sleep-wake disorder (e.g., narcolepsy, a breathing-related sleep disorder, a circadian rhythm sleep-wake disorder, a parasomnia).
  • The insomnia is not attributable to the physiological effects of a substance (e.g., a
    drug of abuse
    , a medication).

The

DSM-IV TR
includes insomnia but does not fully elaborate on the symptoms compared to the DSM-5. Instead of early-morning waking as a symptom, the DSM-IV-TR listed “nonrestorative sleep” as a primary symptom. The duration of the experience was also vague in the DSM-IV-TR. The DSM-IV-TR stated that symptoms had to be present for a month, whereas in the DSM-5 it stated symptoms had to be present for three months and occur at least 3 nights a week (Gillette).

Types

Insomnia can be classified as transient, acute, or chronic.

  • Transient insomnia lasts for less than a week. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe depression, or by stress. Its consequences – sleepiness and impaired psychomotor performance – are similar to those of sleep deprivation.[94]
  • Acute insomnia is the inability to consistently sleep well for a period of less than a month. Insomnia is present when there is difficulty initiating or maintaining sleep or when the sleep that is obtained is non-refreshing or of poor quality. These problems occur despite adequate opportunity and circumstances for sleep and they must result in problems with daytime function.[95] Hyperarousal can be linked to acute insomnia since it activates the body's fight-or-flight response. When we encounter stress or danger, our bodies naturally become more alert, which can interfere with our capacity to both fall asleep and remain asleep. This heightened state of arousal can be useful in the short term during threatening situations, but if it continues over an extended period, it can result in acute insomnia.[96] Acute insomnia is also known as short term insomnia or stress related insomnia.[97]
  • mental fatigue.[94]

Prevention

Prevention and treatment of insomnia may require a combination of cognitive behavioral therapy,[14] medications,[101] and lifestyle changes.[102]

Among lifestyle practices, going to sleep and waking up at the same time each day can create a steady pattern which may help to prevent insomnia.

exercise and caffeinated drinks a few hours before going to sleep is recommended, while exercise earlier in the day may be beneficial.[102] Other practices to improve sleep hygiene may include:[102][103]

  • Avoiding or limiting naps
  • Treating pain at bedtime
  • Avoiding large meals, beverages, alcohol, and nicotine before bedtime
  • Finding soothing ways to relax into sleep, including use of white noise
  • Making the bedroom suitable for sleep by keeping it dark, cool, and free of devices, such as clocks, cell phones, or televisions
  • Maintain regular exercise
  • Try relaxing activities before sleeping

Management

It is recommended to rule out medical and psychological causes before deciding on the treatment for insomnia.[104] Cognitive behavioral therapy is generally the first line treatment once this has been done.[105] It has been found to be effective for chronic insomnia.[14] The beneficial effects, in contrast to those produced by medications, may last well beyond the stopping of therapy.[106]

Medications have been used mainly to reduce symptoms in insomnia of short duration; their role in the management of chronic insomnia remains unclear.[8] Several different types of medications may be used.[107][108][101] Many doctors do not recommend relying on prescription sleeping pills for long-term use.[102] It is also important to identify and treat other medical conditions that may be contributing to insomnia, such as depression, breathing problems, and chronic pain.[102][109] As of 2022, many people with insomnia were reported as not receiving overall sufficient sleep or treatment for insomnia.[110][111]

Non-medication based

Non-medication based strategies have comparable efficacy to

rebound withdrawal effects upon discontinuation or tolerance can develop.[112]

Non medication based strategies provide long lasting improvements to insomnia and are recommended as a first line and long-term strategy of management. Behavioral sleep medicine (BSM) tries to address insomnia with non-pharmacological treatments. The BSM strategies used to address chronic insomnia include attention to sleep hygiene, stimulus control, behavioral interventions, sleep-restriction therapy, paradoxical intention, patient education, and relaxation therapy.[113] Some examples are keeping a journal, restricting the time spent awake in bed, practicing relaxation techniques, and maintaining a regular sleep schedule and a wake-up time.[109] Behavioral therapy can assist a patient in developing new sleep behaviors to improve sleep quality and consolidation. Behavioral therapy may include, learning healthy sleep habits to promote sleep relaxation, undergoing light therapy to help with worry-reduction strategies and regulating the circadian clock.[109]

Music may improve insomnia in adults (see

EEG biofeedback has demonstrated effectiveness in the treatment of insomnia with improvements in duration as well as quality of sleep.[115] Self-help therapy (defined as a psychological therapy that can be worked through on one's own) may improve sleep quality for adults with insomnia to a small or moderate degree.[116]

Stimulus control therapy is a treatment for patients who have conditioned themselves to associate the bed, or sleep in general, with a negative response. As stimulus control therapy involves taking steps to control the sleep environment, it is sometimes referred interchangeably with the concept of sleep hygiene. Examples of such environmental modifications include using the bed for sleep and sex only, not for activities such as reading or watching television; waking up at the same time every morning, including on weekends; going to bed only when sleepy and when there is a high likelihood that sleep will occur; leaving the bed and beginning an activity in another location if sleep does not occur in a reasonably brief period of time after getting into bed (commonly ~20 min); reducing the subjective effort and energy expended trying to fall asleep; avoiding exposure to bright light during night-time hours, and eliminating daytime naps.[117]

A component of stimulus control therapy is sleep restriction, a technique that aims to match the time spent in bed with actual time spent asleep. This technique involves maintaining a strict sleep-wake schedule, sleeping only at certain times of the day and for specific amounts of time to induce mild sleep deprivation. Complete treatment usually lasts up to 3 weeks and involves making oneself sleep for only a minimum amount of time that they are actually capable of on average, and then, if capable (i.e. when

Bright light therapy may be effective for insomnia.[118]

Paradoxical intention is a cognitive reframing technique where the insomniac, instead of attempting to fall asleep at night, makes every effort to stay awake (i.e. essentially stops trying to fall asleep). One theory that may explain the effectiveness of this method is that by not voluntarily making oneself go to sleep, it relieves the performance anxiety that arises from the need or requirement to fall asleep, which is meant to be a passive act. This technique has been shown to reduce sleep effort and performance anxiety and also lower subjective assessment of sleep-onset latency and overestimation of the sleep deficit (a quality found in many insomniacs).[119]

Sleep hygiene

Sleep hygiene is a common term for all of the behaviors which relate to the promotion of good sleep. They include habits which provide a good foundation for sleep and help to prevent insomnia. However, sleep hygiene alone may not be adequate to address chronic insomnia.[88] Sleep hygiene recommendations are typically included as one component of cognitive behavioral therapy for insomnia (CBT-I).[88][6] Recommendations include reducing caffeine, nicotine, and alcohol consumption, maximizing the regularity and efficiency of sleep episodes, minimizing medication usage and daytime napping, the promotion of regular exercise, and the facilitation of a positive sleep environment.[120] The creation of a positive sleep environment may also be helpful in reducing the symptoms of insomnia.[121] On the other hand, a systematic review by the AASM concluded that clinicians should not prescribe sleep hygiene for insomnia due to the evidence of absence of its efficacy and potential delaying of adequate treatment, recommending instead that effective therapies such as CBT-i should be preferred.[13]

Cognitive behavioral therapy

Main article: Cognitive behavioral therapy for insomnia

There is some evidence that cognitive behavioral therapy for insomnia (CBT-I) is superior in the long-term to benzodiazepines and the nonbenzodiazepines in the treatment and management of insomnia.[122] In this therapy, patients are taught improved sleep habits and relieved of counter-productive assumptions about sleep. Common misconceptions and expectations that can be modified include:

  • Unrealistic sleep expectations.
  • Misconceptions about insomnia causes.
  • Amplifying the consequences of insomnia.
  • Performance anxiety after trying for so long to have a good night's sleep by controlling the sleep process.

Numerous studies have reported positive outcomes of combining cognitive behavioral therapy for insomnia treatment with treatments such as stimulus control and the relaxation therapies.

CBT-I have sustained and lasting effects on treating insomnia long after therapy has been discontinued.[123][124] The addition of hypnotic medications with CBT-I adds no benefit in insomnia. The long lasting benefits of a course of CBT-I shows superiority over pharmacological hypnotic drugs. Even in the short term when compared to short-term hypnotic medication such as zolpidem, CBT-I still shows significant superiority. Thus CBT-I is recommended as a first line treatment for insomnia.[125]

Common forms of CBT-I treatments include stimulus control therapy, sleep restriction, sleep hygiene, improved sleeping environments, relaxation training, paradoxical intention, and biofeedback.[126]

CBT is the well-accepted form of therapy for insomnia since it has no known adverse effects, whereas taking medications to alleviate insomnia symptoms have been shown to have adverse side effects.[127] Nevertheless, the downside of CBT is that it may take a lot of time and motivation.[128]

Acceptance and commitment therapy

Treatments based on the principles of

hyperarousal.[130] The ACT approach posits that acceptance of the negative feelings associated with insomnia can, in time, create the right conditions for sleep. Mindfulness
practice is a key feature of this approach, although mindfulness is not practised to induce sleep (this in itself is a sleep effort to be avoided) but rather as a longer-term activity to help calm the nervous system and create the internal conditions from which sleep can emerge.

A key distinction between CBT-i and ACT lies in the divergent approaches to time spent awake in bed. Proponents of CBT-i advocate minimizing time spent awake in bed, on the basis that this creates cognitive association between being in bed and wakefulness. The ACT approach proposes that avoiding time in bed may increase the pressure to sleep and arouse the nervous system further.[130]

Research has shown that "ACT has a significant effect on primary and comorbid insomnia and sleep quality, and ... can be used as an appropriate treatment method to control and improve insomnia".[131]

Internet interventions

Despite the therapeutic effectiveness and proven success of CBT, treatment availability is significantly limited by a lack of trained clinicians, poor geographical distribution of knowledgeable professionals, and expense.[132] One way to potentially overcome these barriers is to use the Internet to deliver treatment, making this effective intervention more accessible and less costly. The Internet has already become a critical source of health-care and medical information.[133] Although the vast majority of health websites provide general information,[133][134] there is growing research literature on the development and evaluation of Internet interventions.[135][136]

These online programs are typically behaviorally-based treatments that have been operationalized and transformed for delivery via the Internet. They are usually highly structured; automated or human supported; based on effective face-to-face treatment; personalized to the user; interactive; enhanced by graphics, animations, audio, and possibly video; and tailored to provide follow-up and feedback.[136]

There is good evidence for the use of computer based CBT for insomnia.[137]

Medications

See also: Somnifacient

Many people with insomnia use

sleeping tablets and other sedatives. In some places medications are prescribed in over 95% of cases.[138] They, however, are a second line treatment.[139] In 2019, the US Food and Drug Administration stated it is going to require warnings for eszopiclone, zaleplon, and zolpidem, due to concerns about serious injuries resulting from abnormal sleep behaviors, including sleepwalking or driving a vehicle while asleep.[140]

The percentage of adults using a prescription sleep aid increases with age. During 2005–2010, about 4% of U.S. adults aged 20 and over reported that they took prescription sleep aids in the past 30 days. Rates of use were lowest among the youngest age group (those aged 20–39) at about 2%, increased to 6% among those aged 50–59, and reached 7% among those aged 80 and over. More adult women (5%) reported using prescription sleep aids than adult men (3%). Non-Hispanic white adults reported higher use of sleep aids (5%) than non-Hispanic black (3%) and Mexican-American (2%) adults. No difference was shown between non-Hispanic black adults and Mexican-American adults in use of prescription sleep aids.[141]

Antihistamines

As an alternative to taking prescription drugs, some evidence shows that an average person seeking short-term help may find relief by taking

antihistamines such as diphenhydramine or doxylamine.[142] Diphenhydramine and doxylamine are widely used in nonprescription sleep aids. They are the most effective over-the-counter sedatives currently available, at least in much of Europe, Canada, Australia, and the United States, and are more sedating than some prescription hypnotics.[143] Antihistamine effectiveness for sleep may decrease over time, and anticholinergic side-effects (such as dry mouth) may also be a drawback with these particular drugs. While addiction does not seem to be an issue with this class of drugs, they can induce dependence and rebound effects upon abrupt cessation of use.[144] However, people whose insomnia is caused by restless legs syndrome may have worsened symptoms with antihistamines.[145]

Antidepressants

While insomnia is a common symptom of depression, antidepressants are effective for treating sleep problems whether or not they are associated with depression. While all antidepressants help regulate sleep, some antidepressants, such as amitriptyline, doxepin, mirtazapine, trazodone, and trimipramine, can have an immediate sedative effect, and are prescribed to treat insomnia.[146] Trazodone was at the beginning of the 2020s the biggest prescribed drug for sleep in the United States despite not being indicated for sleep.[147]

Amitriptyline, doxepin, and trimipramine all have

antiserotonergic properties, which contribute to both their therapeutic effects and side effect profiles, while mirtazapine's actions are primarily antihistaminergic and antiserotonergic and trazodone's effects are primarily antiadrenergic and antiserotonergic. Mirtazapine is known to decrease sleep latency (i.e., the time it takes to fall asleep), promoting sleep efficiency and increasing the total amount of sleeping time in people with both depression and insomnia.[148][149]

Servier.[154]

A 2018

Cochrane review found the safety of taking antidepressants for insomnia to be uncertain with no evidence supporting long term use.[155]

Melatonin agonists

melatonin and ramelteon are used in the treatment of insomnia. The evidence for melatonin in treating insomnia is generally poor.[156] There is low-quality evidence that it may speed the onset of sleep by 6 minutes.[156] Ramelteon does not appear to speed the onset of sleep or the amount of sleep a person gets.[156]

Usage of melatonin as a treatment for insomnia in adults has increased from 0.4% between 1999 and 2000 to nearly 2.1% between 2017 and 2018.[157]

While the use of melatonin in the short-term has been proven to be generally safe and it is shown to not be a dependent medication, side effects can still occur.[158]

Most common side effects of melatonin include:[159]

  • Headache
  • Dizziness
  • Nausea
  • Daytime drowsiness

Prolonged-release melatonin may improve quality of sleep in older people with minimal side effects.[160][161]

Studies have also shown that children who are on the

hyperactivity and, as a result, tend to be tired during most of the day. Another cause of insomnia in children with ADHD is the use of stimulants used to treat their disorder. Children who have ADHD then, as well as the other disorders mentioned, may be given melatonin before bedtime in order to help them sleep.[162]

Benzodiazepines

sleep disorders.[163]

The most commonly used class of hypnotics for insomnia are the benzodiazepines.[58]: 363  Benzodiazepines are not significantly better for insomnia than antidepressants.[164] Chronic users of hypnotic medications for insomnia do not have better sleep than chronic insomniacs not taking medications. In fact, chronic users of hypnotic medications have more regular night-time awakenings than insomniacs not taking hypnotic medications.[165] Many have concluded that these drugs cause an unjustifiable risk to the individual and to public health and lack evidence of long-term effectiveness. It is preferred that hypnotics be prescribed for only a few days at the lowest effective dose and avoided altogether wherever possible, especially in the elderly.[166] Between 1993 and 2010, the prescribing of benzodiazepines to individuals with sleep disorders has decreased from 24% to 11% in the US, coinciding with the first release of nonbenzodiazepines.[167]

The

long-term use of benzodiazepines and is recommended whenever possible.[172][173]

Benzodiazepines all bind unselectively to the GABAA receptor.[164] Some theorize that certain benzodiazepines (hypnotic benzodiazepines) have significantly higher activity at the α1 subunit of the GABAA receptor compared to other benzodiazepines (for example, triazolam and temazepam have significantly higher activity at the α1 subunit compared to alprazolam and diazepam, making them superior sedative-hypnotics – alprazolam and diazepam, in turn, have higher activity at the α2 subunit compared to triazolam and temazepam, making them superior anxiolytic agents). Modulation of the α1 subunit is associated with sedation, motor impairment, respiratory depression, amnesia, ataxia, and reinforcing behavior (drug-seeking behavior). Modulation of the α2 subunit is associated with anxiolytic activity and disinhibition. For this reason, certain benzodiazepines may be better suited to treat insomnia than others.[121]

Z-Drugs

Z-drug sedative–hypnotic drugs, such as zolpidem, zaleplon, zopiclone, and eszopiclone, are a class of hypnotic medications that are similar to benzodiazepines in their mechanism of action, and indicated for mild to moderate insomnia. Their effectiveness at improving time to sleeping is slight, and they have similar—though potentially less severe—side effect profiles compared to benzodiazepines.[174] Prescribing of nonbenzodiazepines has seen a general increase since their initial release on the US market in 1992, from 2.3% in 1993 among individuals with sleep disorders to 13.7% in 2010.[167]

Orexin antagonists

Orexin receptor antagonists are a more recently introduced class of sleep medications and include suvorexant, lemborexant, and daridorexant, all of which are FDA-approved for treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.[175][176] They are oriented towards blocking signals in the brain that stimulate wakefulness, therefore claiming to address insomnia without creating dependence. There are three dual orexin receptor (DORA) drugs on the market: Belsomra (Merck), Dayvigo (Eisai) and Quviviq (Idorsia).[147]

Antipsychotics

Certain

Z-drugs, with most of the risk being driven by cardiovascular death.[185] Laboratory data from an unpublished analysis of the same cohort also support the lack of dose-dependency of metabolic side effects, as new use of low-dose quetiapine was associated with a risk of increased fasting triglycerides at one-year follow-up.[186] Concerns regarding side effects are greater in the elderly.[187]

Other sedatives

Gabapentinoids like gabapentin and pregabalin have sleep-promoting effects but are not commonly used for treatment of insomnia.[188] Gabapentin is not effective in helping alcohol related insomnia.[189][190]

Barbiturates, while once used, are no longer recommended for insomnia due to the risk of addiction and other side effects.[191]

Comparative effectiveness

Medications for the treatment of insomnia have a wide range of

orexin receptor antagonists, and melatonin receptor agonists, the orexin antagonist lemborexant and the Z-drug eszopiclone had the best profiles overall in terms of efficacy, tolerability, and acceptability.[182]

Alternative medicine

quality evidence that they are effective and safe.[192][193][194][195] The same is true for cannabis and cannabinoids.[196][197][198] It is likewise unclear whether acupuncture is useful in the treatment of insomnia.[199]

Prognosis

Disability-adjusted life year for insomnia per 100,000 inhabitants in 2004:
  no data
  less than 25
  25–30.25
  30.25–36
  36–41.5
  41.5–47
  47–52.5
  52.5–58
  58–63.5
  63.5–69
  69–74.5
  74.5–80
  more than 80

A survey of 1.1 million residents in the United States found that those that reported sleeping about 7 hours per night had the lowest rates of mortality, whereas those that slept for fewer than 6 hours or more than 8 hours had higher mortality rates. Severe insomnia – sleeping less than 3.5 hours in women and 4.5 hours in men – is associated with a 15% increase in mortality, while getting 8.5 or more hours of sleep per night was associated with a 15% higher mortality rate.[200]

With this technique, it is difficult to distinguish lack of sleep caused by a disorder which is also a cause of premature death, versus a disorder which causes a lack of sleep, and the lack of sleep causing premature death. Most of the increase in mortality from severe insomnia was discounted after controlling for associated disorders. After controlling for sleep duration and insomnia, use of sleeping pills was also found to be associated with an increased mortality rate.[200]

The lowest mortality was seen in individuals who slept between six and a half and seven and a half hours per night. Even sleeping only 4.5 hours per night is associated with very little increase in mortality. Thus, mild to moderate insomnia for most people is associated with increased longevity and severe insomnia is associated only with a very small effect on mortality.[200] It is unclear why sleeping longer than 7.5 hours is associated with excess mortality.[200]

Epidemiology

Between 10% and 30% of adults have insomnia at any given point in time and up to half of people have insomnia in a given year, making it the most common sleep disorder.[9][8][10][201] About 6% of people have insomnia that is not due to another problem and lasts for more than a month.[9] People over the age of 65 are affected more often than younger people.[7] Females are more often affected than males.[8] Insomnia is 40% more common in women than in men.[202]

There are higher rates of insomnia reported among university students compared to the general population.[203]

Society and culture

The word insomnia is from

Latin: in + somnus "without sleep" and -ia as a nominalizing suffix
.

The

popular press have published stories about people who supposedly never sleep, such as that of Thái Ngọc and Al Herpin.[204] Horne writes "everybody sleeps and needs to do so", and generally this appears true. However, he also relates from contemporary accounts the case of Paul Kern, who was shot in 1915 fighting in World War I and then "never slept again" until his death in 1955.[205]
Kern appears to be a completely isolated, unique case.

References

  1. ^
    NHLBI. 24 March 2022. Archived
    from the original on 28 July 2016. Retrieved 26 November 2023.
  2. ^ a b c d "What Causes Insomnia?". NHLBI. 13 December 2011. Archived from the original on 28 July 2016. Retrieved 9 August 2016.
  3. ^ a b c "How Is Insomnia Diagnosed?". NHLBI. 13 December 2011. Archived from the original on 11 August 2016. Retrieved 9 August 2016.
  4. ISBN 978-0-8493-7449-4
    .
  5. ^ a b c d "How Is Insomnia Treated?". NHLBI. 13 December 2011. Archived from the original on 28 July 2016. Retrieved 9 August 2016.
  6. ^
    PMID 27136449
    .
  7. ^
    S2CID 42686046
    .
  8. ^ a b c d e f g "Dyssomnias" (PDF). WHO. pp. 7–11. Archived from the original (PDF) on 18 March 2009. Retrieved 25 January 2009.
  9. ^
    PMID 17824495
    .
  10. ^
    ISBN 978-1-118-75336-1. Archived
    from the original on 2023-01-12. Retrieved 2017-09-01.
  11. ^
    PMID 22735439
    .
  12. PMID 36231555
    .
  13. ^
    PMID 33164741
    .
  14. ^
    S2CID 21617330
    .
  15. ISBN 978-1-59259-662-1
    .
  16. ^ Insomnia > Complications Archived 8 February 2009 at the Wayback Machine. Mayo Clinic. Retrieved on 5 May 2009
  17. ^ Consumer Reports; Drug Effectiveness Review Project (January 2012). "Evaluating New Sleeping Pills Used to Treat: Insomnia Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs Consumer Reports: 4. Archived (PDF) from the original on 9 December 2013. Retrieved 4 June 2013.
  18. ^ "Symptoms". Archived from the original on 15 April 2019. Retrieved 15 April 2019.
  19. S2CID 30439961
    .
  20. ISBN 978-1-932610-14-7
    .
  21. ISBN 978-0-306-47750-8
    .
  22. ^ "What Causes Insomnia?". Archived from the original on 15 April 2019. Retrieved 24 April 2019.
  23. ^ "What Happens When You Sleep?". 22 December 2009. Archived from the original on 5 March 2017. Retrieved 24 February 2017.
  24. S2CID 24024570
    .
  25. ^
    PMID 21967449
    .
  26. doi:10.1186/s41606-018-0028-9
    .
  27. PMID 30746049
    .
  28. S2CID 198193864
    .
  29. S2CID 207974088
    .
  30. PMID 31778942
    .
  31. S2CID 213952365
    .
  32. PMID 33036443
    .
  33. PMID 32903205
    .
  34. S2CID 230107960
    .
  35. PMID 34163386
    .
  36. PMID 34587944
    .
  37. PMID 35095395
    .
  38. doi:10.1016/j.ecresq.2021.12.008
    .
  39. S2CID 246738576
    .
  40. PMID 35955069
    .
  41. PMID 36259788
    .
  42. PMID 35692715
    .
  43. PMID 36546366
    .
  44. PMID 36638702
    .
  45. PMID 37510507
    .
  46. PMID 37713408
    .
  47. hdl:11585/950006
    .
  48. ^ Moawad, H. (2020) Primary insomnia: A lifelong problem, Psychiatric Times. Available at: https://www.psychiatrictimes.com/view/primary-insomnia-lifelong-problem Archived 2022-12-29 at the Wayback Machine (Accessed: December 29, 2022).
  49. ^ Meadows, G. (2015) The sleep book: How to sleep well every night. London, UK: Orion Publishing Group. p.21
  50. ISBN 978-0-323-18872-2. Archived
    from the original on 2023-03-26. Retrieved 2023-03-19.
  51. ^ a b c d e f "Insomnia". University of Maryland Medical Center. Archived from the original on 3 July 2013. Retrieved 11 July 2013.
  52. PMID 17326547
    .
  53. ^ a b "Insomnia Causes". Mayo Clinic. Archived from the original on 21 October 2013. Retrieved 11 July 2013.
  54. ^ "Restless Legs Syndrome/Periodic Limb Movement Disorder". National Heart Lung and Blood Institute. Archived from the original on 3 August 2013. Retrieved 11 July 2013.
  55. ^
    PMID 17853625
    .
  56. ^
    PMID 26316239
    .
  57. ^ "What causes insomnia?". National Heart, Lung, and Blood Institute. Archived from the original on 3 July 2013. Retrieved 11 July 2013.
  58. ^
    ISBN 978-0-19-923396-0
    .
  59. S2CID 207263711
    .
  60. S2CID 28255648
    .
  61. PMID 17406188
    .
  62. ^ The epidemiological survey of exercise-induced insomnia in chinese athletes Archived 9 September 2009 at the Wayback Machine Youqi Shi, Zhihong Zhou, Ke Ning, Jianhong LIU. Athens 2004: Pre-Olympic Congress.
  63. ^ Schmerler J. "Q&A: Why Is Blue Light before Bedtime Bad for Sleep?". Scientific American. Archived from the original on 16 February 2021. Retrieved 19 October 2018.
  64. PMID 17824495
    .
  65. ^ a b c "What Causes Insomnia?". Sleep Foundation. 2021. Archived from the original on 15 April 2019. Retrieved 26 February 2021.
  66. PMID 26779321
    .
  67. ^ Mendelson WB (2008). "New Research on Insomnia: Sleep Disorders May Precede or Exacerbate Psychiatric Conditions". Psychiatric Times. 25 (7). Archived from the original on 19 October 2009.
  68. PMID 26132482
    .
  69. PMID 28604731
    .
  70. PMID 23932332
    .
  71. ^ Perry L (12 October 2004). "How Hangovers Work". HowStuffWorks. Archived from the original on 15 March 2010. Retrieved 20 November 2011.
  72. ISBN 978-0-19-530659-0
    .
  73. S2CID 1709063
    .
  74. PMID 15531349
    .
  75. PMID 15003439
    .
  76. S2CID 76376646
    .
  77. ^ "Insomnia – Symptoms and causes". Mayo Clinic. Archived from the original on 24 January 2018. Retrieved 5 February 2018.
  78. ^ "Risk Factors For Insomnia". Archived from the original on 19 February 2020. Retrieved 14 April 2019.
  79. doi:10.1016/B978-1-4160-6645-3.00076-1
  80. ^
    PMC 7525655
    .
  81. PMID 19413138
    .
  82. PMID 25846534
    .
  83. PMID 19122760
    .
  84. S2CID 23937236
    .
  85. PMID 25218407
    .
  86. PMID 11033374
    .
  87. ^ a b Passarella, S, Duong, M. "Diagnosis and treatment of insomnia." 2008.
  88. ^
    PMID 18853708. Archived
    (PDF) from the original on 9 February 2015. Retrieved 30 July 2015. Actigraphy is indicated as a method to characterize circadian patterns or sleep disturbances in individuals with insomnia, ...
  89. ^
    ABIM Foundation, American College of Occupational and Environmental Medicine, archived
    from the original on 11 September 2014, retrieved 24 February 2014
  90. PMID 22976557
    .
  91. ^
    S2CID 16823040
    .
  92. ^
    PMID 24019746
    .
  93. ^ "Sleep Wake Disorders." Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C.: American Psychiatric Association, 2013.
  94. ^
    PMID 14626537
    .
  95. ^ "Insomnia – sleeplessness, chronic insomnia, acute insomnia, mental ..." Archived from the original on 29 March 2008. Retrieved 29 April 2008.
  96. PMID 32013124
    .
  97. ^ "Acute Insomnia – What is Acute Insomnia". Sleepdisorders.about.com. Archived from the original on 29 March 2013. Retrieved 10 March 2013.
  98. ^ "Types of Insomnia". Sleep Foundation. 2020-08-31. Archived from the original on 2022-07-14. Retrieved 2022-07-15.
  99. PMID 32013124
    .
  100. ^ Simon H. "In-Depth Report: Causes of Chronic Insomnia". The New York Times. Archived from the original on 8 November 2011. Retrieved 4 November 2011.
  101. ^
    S2CID 51866276
    .
  102. ^ a b c d e "Insomnia: Diagnosis and treatment". Mayo Clinic. 15 October 2016. Archived from the original on 4 October 2017. Retrieved 11 October 2018.
  103. ^ Pathak N (17 January 2017). "Insomnia (Acute & Chronic): Symptoms, Causes, and Treatment". WebMD. Archived from the original on 11 October 2018. Retrieved 11 October 2018.
  104. S2CID 38910586
    .
  105. S2CID 3359815. Archived
    (PDF) from the original on 2020-11-05. Retrieved 2020-09-18.
  106. PMID 17308547
    .
  107. PMID 27998379
    .
  108. PMID 19201632
    .
  109. ^
    PMID 23423421
    .
  110. ^ "Sleep Statistics - Facts and Data About Sleep 2022". Sleep Foundation. 2021-10-25. Archived from the original on 2022-07-15. Retrieved 2022-07-15.
  111. S2CID 19203612
    .
  112. ^ National Prescribing Service (1 February 2010). "Addressing hypnotic medicines use in primary care" Archived 1 November 2013 at the Wayback Machine. NPS News, Vol. 67.
  113. PMID 10533351
    .
  114. PMID 36000763
    .
  115. ISBN 978-1-58890-299-3
    .
  116. PMID 18952469
    .
  117. PMID 21178150
    .
  118. S2CID 3410636. Archived
    from the original on 2021-08-28. Retrieved 2020-06-30.
  119. S2CID 22141056
    .
  120. S2CID 143141307
    .
  121. ^ a b "Insomnia". The Lecturio Medical Concept Library. Archived from the original on 2021-06-24. Retrieved 2021-06-24.
  122. PMID 22631616
    .
  123. PMID 15451764
    .
  124. PMID 10086433
    .
  125. ^ Miller KE (2005). "Cognitive Behavior Therapy vs. Pharmacotherapy for Insomnia". American Family Physician. 72 (2): 330. Archived from the original on 6 June 2011.
  126. PMID 17853625. Archived
    from the original on 2022-07-27. Retrieved 2022-07-15.
  127. PMID 19153052
    .
  128. PMID 23602124
    .
  129. PMID 22975073
    .
  130. ^ a b Meadows, G. (2015) The sleep book: How to sleep well every night. London, UK: Orion Publishing Group, p.2-7
  131. ^ Salari, N., Khazaie, H., Hosseinian-Far, A. et al. The effect of acceptance and commitment therapy on insomnia and sleep quality: A systematic review. BMC Neurol 20, 300 (2020). https://doi.org/10.1186/s12883-020-01883-1
  132. PMID 15951083
    .
  133. ^ a b Fox S, Fallows D (5 October 2005). "Digital Divisions". Internet health resources. Washington, DC: Pew Internet & American Life Project. Archived from the original on 21 October 2005.
  134. doi:10.1037/e378852004-017. Archived
    from the original on 30 December 2012.
  135. ISBN 978-1-84169-679-9
    .
  136. ^
    S2CID 161666
    .
  137. S2CID 10527276
    .
  138. PMID 19458795. Archived from the original
    (PDF) on 12 March 2011.
  139. PMID 27136449
    .
  140. ^ "FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines". US Food and Drug Administration. 30 April 2019. Archived from the original on 2 May 2019. Retrieved 2 May 2019.
  141. ^ Chong Y., Fryar, C.D., and Gu, Q. (2013). Prescription Sleep Aid Use Among Adults: United States, 2005–2010. Archived 2021-08-28 at the Wayback Machine Hyattsville, Md.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
  142. ^ Consumer Reports; Drug Effectiveness Review Project (January 2012). "Evaluating Newer Sleeping Pills Used to Treat: Insomnia. Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs: 3, 8, 11. Archived (PDF) from the original on 9 December 2013. Retrieved 4 June 2013.
  143. ^ DrugBank: DB00366 (Doxylamine) Archived 3 December 2009 at the Wayback Machine. Drugbank.ca. Retrieved on 20 November 2011.
  144. PMID 26609210
    .
  145. ^ "Restless Legs Syndrome Fact Sheet | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Archived from the original on 28 July 2017. Retrieved 29 August 2017.
  146. PMID 15519538
    .
  147. ^ a b Dunleavy, Kevin (2023-04-07). "Idorsia petitions DEA to de-schedule its insomnia drug—plus Merck and Eisai rivals". Fierce Pharma. Archived from the original on 2023-08-31. Retrieved 2023-08-31.
  148. PMID 14658972
    .
  149. S2CID 25351993
    .
  150. S2CID 29745284
    .
  151. ^ "Summary of Product Characteristics" (PDF). European Medicine Agency. Archived (PDF) from the original on 29 October 2014. Retrieved 14 October 2013.
  152. ^ "VALDOXAN® Product Information" (PDF). TGA eBusiness Services. Servier Laboratories Pty Ltd. 23 September 2013. Archived from the original on 24 March 2017. Retrieved 14 October 2013.
  153. ^ Novartis drops future blockbuster agomelatine. Archived 11 November 2011 at the Wayback Machine Scrip Intelligence, 25 October 2011 (retrieved 30 October 2011).
  154. ^ Bentham C (29 March 2006). "Servier and Novartis sign licensing agreement for agomelatine, a novel treatment for depression". Servier UK. Archived from the original on 16 April 2009. Retrieved 15 May 2009.
  155. PMID 29761479
    .
  156. ^
    PMID 26844312
    .
  157. ^ "Use of melatonin supplements rising among adults". National Institutes of Health (NIH). 2022-02-28. Archived from the original on 2022-06-29. Retrieved 2022-06-29.
  158. ^ "Pros and cons of melatonin". Mayo Clinic. Retrieved 2024-05-01.
  159. ^ "Pros and cons of melatonin". Mayo Clinic. Retrieved 2024-05-01.
  160. S2CID 1403262
    .
  161. S2CID 23291045
    .
  162. PMID 21760817
    .
  163. ^ Temazepam Archived 30 May 2013 at the Wayback Machine. Websters-online-dictionary.org. Retrieved on 20 November 2011.
  164. ^
    PMID 17619935
    .
  165. S2CID 20655328
    .
  166. S2CID 40188442
    .
  167. ^
    PMID 26711081
    .
  168. PMID 16284208
    .
  169. PMID 1679317
    .
  170. PMID 10976252
    .
  171. ISBN 978-0-8261-1094-7. Archived
    from the original on 2020-06-04. Retrieved 2020-05-12.
  172. ISBN 978-0-387-27681-6
    .
  173. PMID 20025839
    .
  174. PMID 23248080
    .
  175. S2CID 248119793
    .
  176. ^ "Highlights of prescribing information" (PDF). Archived (PDF) from the original on 12 September 2014.
  177. ^
    PMID 27544830
    .
  178. eISSN 2168-9709
    .
  179. ABIM Foundation, American Psychiatric Association, archived
    from the original on 3 December 2013, retrieved 30 December 2013, which cites
  180. S2CID 9888209
    .
  181. PMID 22973576
    .
  182. ^
    S2CID 250536370
    .
  183. PMID 31860457
    .
  184. S2CID 230507941
    .
  185. PMID 36073694
    .
  186. doi:10.21996/mr3m-1783. Archived
    from the original on 2022-10-18. Retrieved 2022-10-18.
  187. S2CID 38394552
    .
  188. S2CID 3578916
    .
  189. S2CID 252983016. Archived
    from the original on 27 November 2022. Retrieved 21 November 2022.
  190. PMID 34819636
    .
  191. ISBN 978-0-7817-6587-9
    .
  192. ^
    PMID 25644982
    .
  193. ^
    PMID 29356580
    .
  194. ^
    PMID 17561634
    .
  195. ^
    S2CID 34484538
    .
  196. S2CID 227174084
    .
  197. S2CID 219452622
    .
  198. PMID 24726015
    .
  199. PMID 22972087
    .
  200. ^
    PMID 11825133
    .
  201. ^ "What are Sleep Disorders?". Psychiatry.org. Archived from the original on 2022-10-27. Retrieved 2022-10-27.
  202. doi:10.1176/pn.42.10.0040
    .
  203. PMID 26298588
    .
  204. ISBN 978-3-319-30572-1. Archived
    from the original on 2023-01-12. Retrieved 2017-09-01. Everyone sleeps and needs to do so
  205. ISBN 978-3-319-30572-1. Archived
    from the original on 2023-01-12. Retrieved 2017-09-01.

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Insomnia&oldid=1222992368"